Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
XORTX Therapeutics Inc (XRTX)
NASDAQ:XRTX
Holding XRTX?
Track your performance easily
XRTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.52 - $7.52
Previous Close$1.95
Volume156.18K
Average Volume (3M)61.09K
Market Cap
$5.68M
Enterprise Value$2.88M
Total Cash (Recent Filing)C$3.84M
Total Debt (Recent Filing)C$14.04K
Price to Earnings (P/E)―
Beta0.47
Next Earnings
Aug 23, 2024EPS Estimate
-$0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.41
Shares Outstanding2,903,565
10 Day Avg. Volume8,942
30 Day Avg. Volume61,086
Standard Deviation0.34
R-Squared0.01
Alpha0.00410
Financial Highlights & Ratios
Price to Book (P/B)1.31
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
XORTX Therapeutics Inc News
PremiumCompany Announcements
XORTX Therapeutics Inc. Faces Financial Challenges
PremiumCompany Announcements
XORTX Highlights Kidney Disease Study at ASN
PremiumCompany Announcements
XORTX Secures $1.5 Million in Latest Offering
PremiumCompany Announcements
XORTX Therapeutics Announces $1.5 Million Offering
PremiumCompany Announcements
XORTX Therapeutics Advances Precision Kidney CareRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
XRTX FAQ
What was XORTX Therapeutics Inc’s price range in the past 12 months?
XORTX Therapeutics Inc lowest stock price was $1.52 and its highest was $7.52 in the past 12 months.
What is XORTX Therapeutics Inc’s market cap?
Currently, no data Available
When is XORTX Therapeutics Inc’s upcoming earnings report date?
XORTX Therapeutics Inc’s upcoming earnings report date is Aug 23, 2024 which is 90 days ago.
How were XORTX Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is XORTX Therapeutics Inc overvalued?
According to Wall Street analysts XORTX Therapeutics Inc’s price is currently Overvalued.
Does XORTX Therapeutics Inc pay dividends?
XORTX Therapeutics Inc does not currently pay dividends.
What is XORTX Therapeutics Inc’s EPS estimate?
XORTX Therapeutics Inc’s EPS estimate is -$0.5.
How many shares outstanding does XORTX Therapeutics Inc have?
XORTX Therapeutics Inc has 2,903,565 shares outstanding.
What happened to XORTX Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of XORTX Therapeutics Inc?
Currently, no hedge funds are holding shares in XRTX
---
XORTX Therapeutics Inc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
XRTX Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth C$2.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-62.91%
12-Months-Change
Fundamentals
Return on Equity
-57.01%
Trailing 12-Months
Asset Growth
-37.36%
Trailing 12-Months
Company Description
XORTX Therapeutics Inc
XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.
---
XRTX Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering XRTX
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-42.25%
reiterated a buy rating 11 months ago
Copying James Molloy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -42.25% per trade.
---